SecBot SecBot
20-F ·Filed May 27, 2026

ICLR

ICON PLC
BEARISH
Impact 8/10
Horizonweeks Processed5mo ago SEC0001628280-26-038487
Notable filing: 20-F
Actionable Insight ▼ Bearish

The restatement confirms systemic revenue recognition failures and material control weaknesses. Though FY2025 revenue inched up 0.8%, operating income ex-impairments fell ~18% YoY, costs rose, and the $750M buyback consumed cash. With a Nasdaq deficiency notice, the Oct 2025 restructuring, and a class-action lawsuit pending, this is a profoundly negative signal for ICON's accounting credibility and near-term equity performance. Monitor the Q2 2026 6-K amendment for restated quarterly data and the SEC investigation outcome.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$136.80
T+0 close · May 27, 2026 · via day close
Latest settled
+25.90%
T+60 · $172.23
Vs SPY
+24.16%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 28 $136.80entry
  2. T+1 · 6mo ago −0.53%α −0.77% · $136.07
  3. T+5 · 6mo ago +11.70%α +11.38% · $152.80
  4. T+20 · 5mo ago +24.17%α +27.31% · $169.86
  5. T+60 · 3mo ago +25.90%α +24.16% · $172.23

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

ICON plc filed its FY2025 20-F, which restates FY2023 and FY2024 financials due to an Audit Committee investigation that found improper revenue recognition and related control failures. Key corrections include a $92.7M revenue overstatement for FY2024 and a $65.3M overstatement for FY2023. Management disclosed material weaknesses in internal controls over financial reporting, and the company recorded a $364.2M goodwill impairment (Data Solutions) and a $101M impairment of other non-financial assets. The filing also notes the disposal of Symphony Health Solutions on May 8, 2026, and a Nasdaq deficiency notice (from the delayed 20-F) received one day prior.

Key Facts

  • FY2025 revenue: $8,251M vs FY2024 restated $8,189M (0.8% increase).
  • FY2025 GAAP net income: $229M vs FY2024 restated $739M (-69%).
  • FY2025 GAAP EPS diluted: $2.90 vs FY2024 restated $8.90.
  • Goodwill impairment charge: $364.2M (Data Solutions unit).
  • Impairment of non-financial assets: $101M.
  • Revenue restated: FY2024 down $92.7M, FY2023 down $65.3M (improper revenue recognition).
  • Net income restated: FY2024 down $52.3M, FY2023 down $58.1M.
  • Material weaknesses disclosed in internal controls (tone at the top, revenue recognition).
  • FY2025 operating income: $442.8M (5.4% margin) vs FY2024 restated $1,032.4M (12.6% margin).
  • Share buyback in FY2025: $750M (4,504,330 shares at avg. $166.51).
  • Debt at Dec 31, 2025: $3,402.4M net (73% fixed rate).
  • Nasdaq deficiency notice received May 26, 2026 due to late 20-F filing.
  • Symphony Health Solutions disposed May 8, 2026 for HealthVerity equity and $37.5M cash.
  • $500M Bridge Secured Credit Facility entered April 27, 2026 to refinance 2026 Notes.
  • Unaudited Obligor Group revenue FY2025: $7,458M; net income: $697M.

Financial Impact

Revenue overstated by ~$158M cumulatively over FY2023-2024. FY2025 GAAP operating margin collapsed to 5.4% from 12.6% due to $465M in impairment charges. The delayed filing triggered a Nasdaq deficiency notice.

revenuenet-incomeepsoperating-margingoodwilldebtinternal-controls

Risk Factors

  • Potential SEC enforcement action and shareholder lawsuits beyond the consolidated class action.
  • Nasdaq delisting if 20-F compliance is not restored within the cure period.
  • Further credit rating downgrade (Moody's already shifted outlook to stable from positive in Feb 2026).
  • Additional impairment charges if Data Solutions revenue continues to decline.
  • Execution risk on the remediation plan for material weaknesses; further restatements possible.
  • $500M 2026 Notes maturity in July 2026, bridge facility provides liquidity but adds leverage.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
57% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
20-F Filing (Primary)0001628280-26-038487
Exhibit: exhibit212.htm0001628280-26-038487

Track record

25 reports on ICLR

Performance horizon

3 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +33.70% at T+60 after the Aug 6, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $190.43 Now $191.40 +0.51% settles Nov 17
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $194.65 to $191.40 Now $191.40 −1.67% ▼ −1.67% +0.24% vs SPY
  3. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $204.63 to $199.70 Now $191.40 −6.47% ▼ −2.41% −3.73% vs SPY
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $201.65 to $204.74 Now $191.40 −5.08% ▲ +1.53% +1.22% vs SPY
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $203.11 to $201.65 Now $191.40 −5.77% ▼ −0.72% +3.69% vs SPY
  6. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $203.11 to $201.65 Now $191.40 −5.77% ▼ −0.72% +3.69% vs SPY
  7. Nov 2, 202614d ago 144 Neutral 2/10 Entry $203.77 to $203.11 Now $191.40 −6.07% ▼ −0.32% −1.98% vs SPY
  8. Nov 2, 202614d ago 144 Neutral 2/10 Entry $203.77 to $203.11 Now $191.40 −6.07% ▼ −0.32% −1.98% vs SPY
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $203.77 to $203.11 Now $191.40 −6.07% ▼ −0.32% −1.98% vs SPY
  10. Oct 27, 202620d ago 6-K Bearish 5/10 Entry $214.16 to $215.48 Now $191.40 +10.63% ▼ −0.62% −1.00% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (11h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 27, 2026